Postlicensure Evaluation of COVID-19 Vaccines.

@article{Patel2020PostlicensureEO,
  title={Postlicensure Evaluation of COVID-19 Vaccines.},
  author={Manish M. Patel and Michael L. Jackson and Jill M. Ferdinands},
  journal={JAMA},
  year={2020}
}
After rigorous clinical trials of vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have established safety and efficacy, and after vaccines are deployed, evaluating vaccine performance in actual clinical settings will be essential for understanding the risks and benefitsofvaccinationprograms.However,uniqueaspects of coronavirus disease 2019 (COVID-19) may pose challenges for these postmarketing approaches for evaluating vaccines… Expand
Covid-19 Vaccine Effectiveness in Healthcare Personnel in six Israeli Hospitals (CoVEHPI)
TLDR
The authors' prospective VE study of HCP in Israel with rigorous weekly surveillance found very high VE for two doses of Pfizer BNT162b2 mRNA vaccine against SARS-CoV-2 during a period of predominant alpha variant circulation. Expand
Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists
TLDR
A look back at the initial clinical experience of the emergency use authorization of BNT162b2, mRNA‐1273, and Ad26 can be used by the global community to inform and develop COVID‐19 vaccine programs. Expand
Prevention of COVID-19 by mRNA-based vaccines within the general population of California
Estimates of COVID-19 vaccine effectiveness under real-world conditions, and understanding of barriers to uptake, are necessary to inform vaccine rollout.We enrolled cases (testing positive) andExpand
Prevention of COVID-19 by mRNA-based vaccines within the general population of California
  • K. Andrejko, J. Pry, +5 authors J. Lewnard
  • Medicine
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2021
TLDR
Authorized mRNA-based vaccines are effective at reducing documented SARS-CoV-2 infections within the general population of California and through the matched odds ratio of prior vaccination, comparing cases with controls. Expand
Early evidence of COVID-19 vaccine effectiveness within the general population of California
TLDR
O Ongoing vaccination efforts are preventing SARS-CoV-2 infection in the general population in California, and vaccine hesitancy did not significantly differ by age, sex, household income, or race/ethnicity. Expand
Using observational epidemiology to evaluate COVID-19 vaccines: integrating traditional methods with new data sources and tools
  • C. Chambers
  • Medicine
  • Canadian Journal of Public Health
  • 2021
TLDR
It is argued that a hybrid approach that combines new data sources and tools, including CO VID-19 vaccine registries, with traditional epidemiological methods will be needed to evaluate COVID-19 vaccines using observational epidemiology. Expand
Coverage and effectiveness of mRNA SARS-CoV-2 vaccines among United States Veterans
TLDR
Vets are effective in reducing SARS-CoV-2 infections and disease-related severity and mortality in the Veteran population and effective vaccine, as well as their efficient and equitable distribution, are important for reducing COVID-19 disease burden among Veterans. Expand
Theoretical framework for retrospective studies of the effectiveness of SARS-CoV-2 vaccines
TLDR
The theoretical basis for estimation of vaccine direct effects under TCC and TND frameworks is reviewed, addressing specific natural history parameters of SARS-CoV-2 infection and COVID-19 relevant to these designs. Expand
Coverage and Estimated Effectiveness of mRNA COVID-19 Vaccines Among US Veterans
TLDR
The findings suggest that early vaccination rollout for veterans was efficient, and estimated VE was high for this diverse US population. Expand
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
TLDR
The odds of experiencing a non-COVID-19 hospitalization decreased with time since vaccination, suggesting a possible underestimation of waning protection by this approach due to confounding factors and providing reassurance that BNT162b2 continues to protect against symptomatic SARS-CoV-2 infection several months after full vaccination. Expand
...
1
2
...

References

SHOWING 1-10 OF 10 REFERENCES
Interpreting Diagnostic Tests for SARS-CoV-2.
TLDR
How to interpret 2 types of diagnostic tests commonly in use for SARS-CoV-2 infections—reverse transcriptase–polymerase chain reaction (RT-PCR) and IgM and IgG enzyme-linked immunosorbent assay (ELISA)—and how the results may vary over time is described. Expand
Evaluating new vaccines for developing countries. Efficacy or effectiveness?
TLDR
The use of effectiveness trials should enable more rational triaging of new vaccines for developing countries and may accelerate the introduction of new vaccine into public health practice by resolving speculative debates about practical costs and benefits. Expand
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19): A Review.
TLDR
This review discusses current evidence regarding the pathophysiology, transmission, diagnosis, and management of COVID-19, the novel severe acute respiratory syndrome coronavirus 2 pandemic that has caused a worldwide sudden and substantial increase in hospitalizations for pneumonia with multiorgan disease. Expand
Fulfilling the promise of rotavirus vaccines: how far have we come since licensure?
TLDR
Rotavirus vaccination has led to large, sustained declines in childhood deaths from diarrhoea in Brazil and Mexico, which supports estimates that rotavirus was the leading cause of diarrhoeal deaths in these countries. Expand
The use of test-negative controls to monitor vaccine effectiveness: a systematic review of methodology.
TLDR
If vaccination reduces disease severity in breakthrough infections, particular care must be taken in interpreting vaccine effectiveness estimates from test-negative design studies, including studies on VE against influenza virus, rotavirus, and nine other pathogens. Expand
Effects of imperfect test sensitivity and specificity on observational studies of influenza vaccine effectiveness.
TLDR
Although influenza test misclassification causes more bias in test-negative studies than in traditional cohort or case-control studies, the difference is trivial for realistic combinations of attack rates, test sensitivity/specificity, and VE. Expand
The Environment and Disease: Association or Causation?
  • A. B. Hill
  • Medicine
  • Proceedings of the Royal Society of Medicine
  • 1965
TLDR
This paper contrasts Bradford Hill’s approach with a currently fashionable framework for reasoning about statistical associations – the Common Task Framework – and suggests why following Bradford Hill, 50+ years on, is still extraordinarily reasonable. Expand
Effectiveness ∗
We describe axiomatizations of several aspects of effectiveness: effectiveness of transitions; effectiveness relative to oracles; and absolute effectiveness, as posited by the Church-Turing Thesis.Expand
  • 2009
Generic Protocol for Monitoring Impact of Rotavirus Vaccination on Rotavirus Disease Burden and Viral Strains. World Health Organization
  • 2009